Intersect Ent Inc
NASDAQ:XENT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intersect Ent Inc
Total Liabilities
Intersect Ent Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Total Liabilities
$221.4m
|
CAGR 3-Years
122%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities
$28.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities
$16.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities
$20.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities
$33.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities
$1.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
See Also
What is Intersect Ent Inc's Total Liabilities?
Total Liabilities
221.4m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Total Liabilities amounts to 221.4m USD.
What is Intersect Ent Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
75%
Over the last year, the Total Liabilities growth was 40%. The average annual Total Liabilities growth rates for Intersect Ent Inc have been 122% over the past three years , 75% over the past five years .